{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-210379","form_type":"8-K","ticker":"TSNDF","cik":"0001778129","company_name":"TerrAscend Corp.","filed_at":"2026-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.889602+00:00","generated_at":"2026-05-14T21:56:51.030807+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TerrAscend Q1 2026: revenue $65.5M, adj EBITDA $17.4M, 15th consecutive positive cash flow","bullets":["Net revenue $65.5M, +1.9% YoY; gross margin 52.8% vs 53.9% a year ago.","GAAP net loss from cont ops $6.8M vs $7.7M YoY; Adj EBITDA $17.4M (26.5% margin).","Net cash from cont ops $8.7M; free cash flow $7.8M; 15th straight quarter positive ops cash flow.","U.S. medical cannabis rescheduled to Schedule III post-quarter, eliminating 280E tax on medical cannabis.","Appointed Eric Jackson as CFO effective April 2026; executed NCIB repurchases of 115k shares at ~$0.66."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-210379","json":"https://secwatch.observer/filing/0001193125-26-210379.json","markdown":"https://secwatch.observer/filing/0001193125-26-210379.md","text":"https://secwatch.observer/filing/0001193125-26-210379.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1778129/000119312526210379/0001193125-26-210379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1778129/000119312526210379/tsndf-20260507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T21:56:51.030807+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d4fe2f596fa0acd797be303ff00a425d2351734b","claim":"TerrAscend Corp. reported first quarter ended March 31, 2026 results: revenue $65.5 million, net income ($6.8 million).","evidence_excerpt":"Net Revenue of $65.5 million, compared to $64.3 million in the first quarter of 2025 • Gross Profit Margin of 52.8% • GAAP Net Loss from continuing operations was $6.8 million • EBITDA from continuing operations1 was $17.3 million • Adjusted EBITDA from continuing operations1 was $17.4 million or 26.5% of net revenue • Net Cash provided from continuing operations was $8.7 million • Free Cash Flow1 was $7.8 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1778129/000119312526210379/0001193125-26-210379-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"$65.5 million"},{"label":"Net income","value":"($6.8 million)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}